OSL.AX

Healthcare Medical Devices

OncoSil Medical Limited

A$0.73

-0.06 -7.59% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 2:21 PM ET	0.73

Key Stats

Market Cap

26.79M

Avg Volume

192,691

EPS

-A$0.44

52W High

A$1.81

52W Low

A$0.37

Div. Yield

0.0%

Analyst Ratings

Strong Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.04

P/B Ratio

4.51

P/S Ratio

5.26

EV/EBITDA

-1.46

EV/Revenue

3.16

Margins

Gross Margin 53.7%

Operating Margin (336.6%)

Net Margin (213.4%)

EBITDA Margin (216.2%)

Growth & Returns

Revenue Growth (YoY)

248.1%

Return on Equity

(268.2%)

Return on Assets

(78.8%)

Liquidity & Leverage

Current Ratio

1.77

Quick Ratio

1.68

Debt / Equity

0.00

Total Cash

6.48M

Total Debt

14,782

About

OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.